Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Issued: 2022-2025

Historic Shares Issued for Roivant Sciences (ROIV) over the last 4 years, with Mar 2025 value amounting to $49.6 million.

  • Roivant Sciences' Shares Issued rose 931.63% to $68.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.0 million, marking a year-over-year decrease of 63.36%. This contributed to the annual value of $49.6 million for FY2025, which is 75.18% down from last year.
  • Per Roivant Sciences' latest filing, its Shares Issued stood at $49.6 million for FY2025, which was down 75.18% from $199.8 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Shares Issued ranged from a high of $312.0 million in FY2023 and a low of $412,000 during FY2022.
  • For the 3-year period, Roivant Sciences' Shares Issued averaged around $187.1 million, with its median value being $199.8 million (2024).
  • In the last 5 years, Roivant Sciences' Shares Issued spiked by 75,623.54% in 2023 and then plummeted by 75.18% in 2025.
  • Yearly analysis of 4 years shows Roivant Sciences' Shares Issued stood at $412,000 in 2022, then surged by 75,623.54% to $312.0 million in 2023, then tumbled by 35.95% to $199.8 million in 2024, then plummeted by 75.18% to $49.6 million in 2025.